Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions
M. Blanca Piazuelo, Luis Eduardo Bravo, Robertino M. Mera, et al.
Gastroenterology (2020) Vol. 160, Iss. 4, pp. 1106-1117.e3
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report
Peter Malfertheiner, Françis Mégraud, Theodore Rokkas, et al.
Gut (2022) Vol. 71, Iss. 9, pp. 1724-1762
Open Access | Times Cited: 819
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
Aaron P. Thrift, Theresa Nguyen Wenker, Hashem B. El–Serag
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 338-349
Closed Access | Times Cited: 355
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shailja C. Shah, M. Blanca Piazuelo, Ernst J. Kuipers, et al.
Gastroenterology (2021) Vol. 161, Iss. 4, pp. 1325-1332.e7
Open Access | Times Cited: 285
Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up
Lingjun Yan, Ying Chen, Fa Chen, et al.
Gastroenterology (2022) Vol. 163, Iss. 1, pp. 154-162.e3
Open Access | Times Cited: 151
The immune microenvironment in gastric adenocarcinoma
Yana Zavros, Juanita L. Merchant
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 451-467
Open Access | Times Cited: 96
Controlling Gastric Cancer in a World of Heterogeneous Risk
Robert J. Huang, Monika Laszkowska, Haejin In, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 736-751
Closed Access | Times Cited: 56
Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States
Dan Li, Sheng‐Fang Jiang, Nan Ye Lei, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 391-401.e2
Open Access | Times Cited: 45
RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
Massimo Rugge, Robert M. Genta, Peter Malfertheiner, et al.
Gut (2024), pp. gutjnl-331164
Open Access | Times Cited: 41
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa’s cascade underlie its therapeutic effects
Qingsong Liu, Jianyuan Tang, Shuanglan Chen, et al.
Pharmacological Research (2022) Vol. 184, pp. 106440-106440
Closed Access | Times Cited: 58
Gastric Cancer
Dalton A. Norwood, Eleazar E. Montalvan-Sanchez, Ricardo L. Domínguez, et al.
Gastroenterology Clinics of North America (2022) Vol. 51, Iss. 3, pp. 501-518
Closed Access | Times Cited: 52
Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial
Kai‐Feng Pan, Wenqing Li, Lian Zhang, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3250-3260
Closed Access | Times Cited: 16
Screening for Helicobacter pylori to Prevent Gastric Cancer
Yi‐Chia Lee, Tsung‐Hsien Chiang, Han‐Mo Chiu, et al.
JAMA (2024) Vol. 332, Iss. 19, pp. 1642-1642
Closed Access | Times Cited: 12
Effect of Helicobacter pylori–induced gastric cancer on gastrointestinal microbiota: a narrative review
Mohsen Heidary, Sousan Akrami, Tohid Madanipour, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies.
Alexander C. Ford, Yuhong Yuan, Jin Young Park, et al.
Gastroenterology (2025)
Open Access | Times Cited: 1
ACG Clinical Guideline: Diagnosis and Management of Gastric Premalignant Conditions
Douglas R. Morgan, Juan E. Corral, Dan Li, et al.
The American Journal of Gastroenterology (2025)
Closed Access | Times Cited: 1
Gastritis: The clinico-pathological spectrum
Massimo Rugge, Edoardo Savarino, Marta Sbaraglia, et al.
Digestive and Liver Disease (2021) Vol. 53, Iss. 10, pp. 1237-1246
Closed Access | Times Cited: 51
Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up
Alexander C. Ford, Yuhong Yuan, Paul Moayyedi
Gastroenterology (2022) Vol. 163, Iss. 3, pp. 754-756.e1
Open Access | Times Cited: 29
Construction of Tongue Image-Based Machine Learning Model for Screening Patients with Gastric Precancerous Lesions
Changzheng Ma, Peng Zhang, Shiyu Du, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 271-271
Open Access | Times Cited: 19
Guidelines for diagnosis and treatment of chronic gastritis inChina(2022,Shanghai)

Journal of Digestive Diseases (2023) Vol. 24, Iss. 3, pp. 150-180
Closed Access | Times Cited: 18
Helicobacter pylori Treatment and Gastric Cancer Risk After Endoscopic Resection of Dysplasia: A Nationwide Cohort Study
Hae Won Yoo, Su Jin Hong, Shin Hee Kim
Gastroenterology (2023) Vol. 166, Iss. 2, pp. 313-322.e3
Open Access | Times Cited: 18
Gastric cancer screening in Western countries: A call to action
Fabio Farinati, Filippo Pelizzaro
Digestive and Liver Disease (2024) Vol. 56, Iss. 10, pp. 1653-1662
Closed Access | Times Cited: 8
Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication
Wai K. Leung, Ka Shing Cheung, Bofei Li, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 53, Iss. 8, pp. 864-872
Closed Access | Times Cited: 40
Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia
Su‐Hyung Lee, Bo Gun Jang, Jimin Min, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 1, pp. 199-217
Open Access | Times Cited: 39
Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway
Wenhao Liao, Yueqiang Wen, Jing Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 302, pp. 115885-115885
Closed Access | Times Cited: 23
Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial
Shasha Chen, Weina Shen, Yuhuan Liu, et al.
Chinese Medical Journal (2023) Vol. 136, Iss. 14, pp. 1690-1698
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top